Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in isolated rat lung and liver

被引:16
|
作者
Schrader E. [1 ]
Hirsch-Ernst K.I. [1 ]
Richter E. [2 ]
Foth H. [3 ]
机构
[1] Institute of Toxicology, University of Göttingen, D-37075 Göttingen
[2] Walther-Straub Inst. Pharmacol. T., Ludwig Maximilians Univ. Munchen, D-80336 München
[3] Inst. of Environmental Toxicology, Martin Luther Univ. Halle-Wittenberg, D-06097 Halle/Saale
关键词
Elimination kinetics; Liver; Lung; Metabolism; N-oxide; NNK; Perfusion; Rat;
D O I
10.1007/PL00005176
中图分类号
学科分类号
摘要
The tobacco specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) is a strong lung carcinogen in all species tested. To elicit its tumorigenic effects NNK requires metabolic activation which is supposed to take place via a-hydroxylation, whereas N-oxidation is suggested to be a detoxification pathway. The differences in the organ specific metabolism of NNK may be crucial for the organotropy in NNK-induced carcinogenesis. Therefore, metabolism of NNK was investigated in the target organ lung and in liver of Fischer 344 (F344) rats using the model of isolated perfused organs. High activity to metabolize 35 nM [5-3H]NNK was observed in both perfused organs. NNK was eliminated by liver substantially faster (clearance 6.9 ± 1.6 ml/min, half-life 14.6 ± 1.2 min) than by lung (clearance 2.1 ± 0.5 ml/min, half-life 47.9 ± 7.4 min). When the clearance is calculated for a gram of organ or for metabolically active cell forms, the risk with respect to carcinogenic mechanisms was higher in lung than in liver. The metabolism of NNK in liver yielded the two products of NNK α-hydroxylation, the 4-oxo-4-(3-pyridyl)-butyric acid (keto acid) and 4-hydroxy-4-(3-pyridyl)-butyric acid (hydroxy acid). In lung, the major metabolite of NNK was 4-(methylnitrosamino)-1-(3-pyridyl-N-oxide)-1-butanone (NNK-N-oxide). Substantial amounts of metabolites formed from methyl hydroxylation of NNK, which is one of the two possible pathways of α-hydroxylation, were detected in lung but not in liver perfusion. Formation of these metabolites (4-oxo-4-(3-pyridyl)-butanol (keto alcohol), and 4-hydroxy-4-(3-pyridyl)-butanol (diol) can give rise to pyridyloxobutylating of DNA. When isolated rat livers were perfused with 150 μM NNK, equal to a dosage which is sufficient to induce liver tumors in rat, glucuronidation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) was increased when compared to the concentration of 35 nM NNK. Nevertheless, the main part of NNK was also transformed via α-hydroxylation for this high concentration of NNK.
引用
收藏
页码:336 / 343
页数:7
相关论文
共 50 条
  • [41] SYNTHESIS OF 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE, 4-(CARBETHOXYNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE, AND N'-NITROSONORNICOTINE LABELED WITH TRITIUM IN THE PYRIDINE RING
    WILEY, JC
    CHIEN, DHT
    NUNGESSER, NA
    LIN, D
    HECHT, SS
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 1988, 25 (07): : 707 - 716
  • [42] Disposition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in bile duct-cannulated rats: Stereoselective metabolism and tissue distribution
    Wu, Z
    Upadhyaya, P
    Carmella, SG
    Hecht, SS
    Zimmerman, CL
    CARCINOGENESIS, 2002, 23 (01) : 171 - 179
  • [43] Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) metabolism in human hepatic microsomes by ipomeanol analogs - An exploratory study
    Nunes, MG
    Desai, D
    Koehl, W
    Spratt, TE
    Guengerich, FP
    Amin, S
    CANCER LETTERS, 1998, 129 (02) : 131 - 138
  • [44] Tobacco Carcinogen NNK (4-[Methylnitrosamino]-1-[3-Pyridyl]-1-Butanone) Initiates and Sensitizes Acute Pancreatitis Responses
    Alexandre, Martine
    Minervini, Samantha N.
    Patel, Vikhil
    Uduman, Abdul-Kareem
    Shugrue, Christine
    Gorelick, Fred S.
    Thrower, Edwin C.
    GASTROENTEROLOGY, 2011, 140 (05) : S387 - S387
  • [45] Absolute configuration of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol formed metabolically from 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone
    Hecht, SS
    Spratt, TE
    Trushin, N
    CARCINOGENESIS, 1997, 18 (09) : 1851 - 1854
  • [46] 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) metabolism-related enzymes gene polymorphisms, NNK metabolites levels and urothelial carcinoma
    Chung, Chi-Jung
    Pu, Yeong-Shiau
    Shiue, Horng-Sheng
    Lee, Hui-Ling
    Lin, Pinpin
    Yang, Hsiu-Yuan
    Su, Chien-Tien
    Hsueh, Yu-Mei
    TOXICOLOGY LETTERS, 2013, 216 (01) : 16 - 22
  • [47] Tissue distributions of 4-(hydroxymethylnitrosamino)-1-(3-pyridyl)-1-butanone glucuronide, a stable form of reactive intermediate produced from 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, in the rat
    Nishiyama, Takahito
    Ogura, Kenichiro
    Ohnuma, Tomokazu
    Hiratsuka, Akira
    JOURNAL OF TOXICOLOGICAL SCIENCES, 2014, 39 (02): : 263 - 267
  • [48] DETERMINANTS OF A GENOTOXIC EFFECT OF 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE (NNK) IN HUMAN-DIPLOID FIBROBLASTS
    POHLMANN, C
    KOOPS, F
    BERG, J
    HOLZ, O
    EHLERT, U
    RUDIGER, HW
    CLINICAL INVESTIGATOR, 1992, 70 (3-4): : 295 - 298
  • [49] The tobacco specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) induces apoptosis of endothelial cells
    Tithof, PK
    Weddle, D
    Schuller, HM
    Barnhill, M
    FASEB JOURNAL, 2000, 14 (04): : A455 - A455
  • [50] Effect of nicotine, cotinine and phenethyl isothiocyanate on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) metabolism in the Syrian golden hamster
    Richter, E
    Tricker, AR
    TOXICOLOGY, 2002, 179 (1-2) : 95 - 103